{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F7541b459-ec30-4d6b-a7cf-f22c775c093f","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Multiple Myeloma \u2014 Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/7541b459-ec30-4d6b-a7cf-f22c775c093f\"></iframe>","title":"Multiple Myeloma \u2014 Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series","description":"\n        <p>Prof Philippe Moreau of University Hospital \u2013 CHU de Nantes in France, Dr Robert Z Orlowski of The University of Texas MD Anderson Cancer Center in Houston, Dr Noopur Raje of Massachusetts General Hospital Cancer Center in Boston, Dr Paul G Richardson of Dana-Farber Cancer Institute in Boston, and Dr Sagar Lonial of Winship Cancer Institute of Emory University in Atlanta, Georgia, discuss current questions and controversies in the management of multiple myeloma. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/ASHMM24\" rel=\"nofollow\">here</a>.</p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/ac7bfc72-ac4c-4042-b489-18d4d7bd83b3/cover.jpg"}